Prices delayed by at least 15 minutes | Print
CellaVision AB (CEVI)
This share can be held in a Dealing accountISALifetime ISAJISASIPP
Company profile
CellaVision AB is engaged in the business of supplying digital solutions for blood and body fluid analysis. Its solutions are based on digital image analysis technology, artificial intelligence, and information technology. The firm's product portfolio consists of CellaVision peripheral blood application, CellaVision advanced RBC application, and CellaVision remote review software. Its customers include mainly large hospital laboratories and commercial laboratories in North America, Europe and China, and Japan. The company derives the majority of its revenue from the sale of analyzers/software.
Address
Forecast key dates
| Name | Key Date |
|---|---|
| CellaVision AB Annual General Meeting for 2025 | 2025-05-02T15:00:00 |
| CellaVision AB First Quarter Earnings Conference Call for 2025 | 2025-04-25T11:00:00 |
| CellaVision AB First Quarter Earnings Results for 2025 | 2025-04-25T07:20:00 |
| CellaVision AB Annual Report for 2024 | 2025-04-11T00:00:00 |
| CellaVision AB Fourth Quarter Earnings Conference Call for 2024 | 2025-02-06T00:00:00 |
| CellaVision AB Fourth Quarter Earnings Result for 2024 | 2025-02-06T00:00:00 |
| CellaVision AB Third Quarter Earnings Conference Call for 2024 | 2024-10-24T00:00:00 |
| CellaVision AB Third Quarter Earnings Result for 2024 | 2024-10-24T00:00:00 |
| CellaVision AB Second Quarter Earnings Conference Call for 2024 | 2024-07-19T00:00:00 |
| CellaVision AB Second Quarter Earnings Result for 2024 | 2024-07-19T00:00:00 |
| CellaVision AB Annual General Meeting for 2024 | 2024-05-03T15:00:00 |
Previous key dates
| Name | Key Date |
|---|---|
| CellaVision AB Annual General Meeting for 2024 | 2024-05-03T15:00:00 |
| CellaVision AB First Quarter Earnings Conference Call for 2024 | 2024-04-25T11:00:00 |
| CellaVision AB First Quarter Earnings Results for 2024 | 2024-04-25T07:20:00 |
| CellaVision AB Annual Report for 2023 | 2024-04-11T00:00:00 |
| CellaVision AB Fourth Quarter Earnings Conference Call for 2023 | 2024-02-07T11:00:00 |
| CellaVision AB Fourth Quarter Earnings Results for 2023 | 2024-02-07T07:20:00 |
| CellaVision AB Third Quarter Earnings Conference Call for 2023 | 2023-10-25T11:00:00 |
| CellaVision AB Third Quarter Earnings Results for 2023 | 2023-10-25T07:20:00 |
| CellaVision AB Second Quarter Earnings Conference Call for 2023 | 2023-07-20T11:00:00 |
| CellaVision AB Second Quarter Earnings Results for 2023 | 2023-07-20T07:20:00 |
| CellaVision AB Annual General Meeting for 2022 | 2023-05-05T15:00:00 |
| CellaVision AB First Quarter Earnings Conference Call for 2023 | 2023-05-04T11:00:00 |
| CellaVision AB First Quarter Earnings Results for 2023 | 2023-05-04T07:20:00 |
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2024 AJ Bell. All rights reserved.